JP Morgan Chase & Co’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $81.6K | Sell |
|
|||||
|
2025
Q2 | $161K | Sell |
|
|||||
|
2025
Q1 | $139K | Buy |
|
|||||
|
2024
Q4 | $94.6K | Buy |
|
|||||
|
2024
Q3 | $143K | Buy |
|
|||||
|
2024
Q2 | $133K | Sell |
|
|||||
|
2024
Q1 | $902K | Buy |
|
|||||
|
2023
Q4 | $275K | Buy |
|
|||||
|
2023
Q3 | $109K | Sell |
|
|||||
|
2023
Q2 | $194K | Sell |
|
|||||
|
2023
Q1 | $3.04M | Buy |
|
|||||
|
2022
Q4 | $185K | Buy |
|
|||||
|
2022
Q3 | $4K | Sell |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $9K | Buy |
|
|||||
|
2021
Q4 | $17K | Buy |
|
|||||
|
2021
Q3 | $13K | Buy |
|
|||||
|
2021
Q2 | $7K | Buy |
|
|||||
|
2021
Q1 | $0 | Hold |
|
|||||
|
2020
Q4 | $0 | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $124K | Buy |
|
|||||
|
2019
Q1 | $246K | Buy |
|
|||||
|
2018
Q4 | $39K | Buy |
|
|||||
|
2018
Q3 | $83K | Sell |
|
|||||
|
2018
Q2 | $413K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $2.31M | Buy |
|
|||||
|
2016
Q4 | $152K | Buy |
|
|||||
|
2016
Q3 | $151K | Sell |
|
|||||
|
2016
Q2 | $291K | Sell |
|
|||||
|
2016
Q1 | $2.61M | Sell |
|
|||||
|
2015
Q4 | $2.64M | Buy |
|
|||||
|
2015
Q3 | $6.09M | Buy |
|
|||||
|
2015
Q2 | $4M | Buy |
|
|||||
|
2015
Q1 | $4.24M | Sell |
|
|||||
|
2014
Q4 | $3.36M | Sell |
|
|||||
|
2014
Q3 | $2.42M | Buy |
|